Haemonetics (STU:HAZ) Total Liabilities : €1,137 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Haemonetics Total Liabilities?

Haemonetics's Total Liabilities for the quarter that ended in Mar. 2024 was €1,137 Mil.

Haemonetics's quarterly Total Liabilities increased from Sep. 2023 (€1,047.21 Mil) to Dec. 2023 (€1,152.77 Mil) but then declined from Dec. 2023 (€1,152.77 Mil) to Mar. 2024 (€1,136.78 Mil).

Haemonetics's annual Total Liabilities increased from Mar. 2022 (€1,008.16 Mil) to Mar. 2023 (€1,043.12 Mil) and increased from Mar. 2023 (€1,043.12 Mil) to Mar. 2024 (€1,136.78 Mil).

Haemonetics Total Liabilities Historical Data

The historical data trend for Haemonetics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haemonetics Total Liabilities Chart

Haemonetics Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Total Liabilities

Get a 7-Day Free Trial

615.40

914.13

1,008.16

1,043.12

1,136.78

Haemonetics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1,043.12	1,013.12	1,047.21	1,152.77	1,136.78

Haemonetics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Haemonetics's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	276.352	+	(733.759	+	69.038
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	57.632	+	0)
	=	1,137

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	2019.944	-	883.162
	=	1,137

Haemonetics's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	276.352	+	(733.759	+	69.038
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	57.632	+	0)
	=	1,137

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	2019.944	-	883.162
	=	1,137

Haemonetics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Haemonetics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Haemonetics (STU:HAZ) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Haemonetics Corp (STU:HAZ) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

HAE:USA

Address

125 Summer Street, Boston, MA, USA, 02110

Website

https://www.haemonetics.com

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company places primary emphasis on its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Haemonetics (STU:HAZ) Headlines

No Headlines